Related Experiment Video
Updated: May 24, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Towards the Definition of a Prognostic Model for Mantle Cell Lymphoma
Simone Ferrero1, Riccardo Francia2, Marco Ladetto2
1University of Turin, Turin, Italy.
Studies in Health Technology and Informatics
|May 23, 2026
Summary
Developing a new prognostic model for mantle cell lymphoma (MCL) using AutoML-Med offers improved risk assessment. This explainable AI model outperforms existing tools for personalized patient care.
Area of Science:
- Oncology
- Biostatistics
- Artificial Intelligence in Medicine
Background:
- Mantle cell lymphoma (MCL) exhibits variable clinical behavior, necessitating advanced prognostic tools.
- Current prognostic indexes for MCL may lack the precision required for effective risk-adapted management.
- The need for a tailored, robust prognostic model for specific MCL patient cohorts is evident.
Purpose of the Study:
- To develop and validate an effective, deployable prognostic model for mantle cell lymphoma.
- To leverage AutoML-Med for creating an explainable predictive tool for MCL.
- To improve risk stratification for patients with mantle cell lymphoma.
Main Methods:
- Utilized the AutoML-Med framework to facilitate the data analysis pipeline.
- Developed a prognostic model specifically tailored to a defined mantle cell lymphoma population.
- Employed machine learning techniques for model creation and validation.
Main Results:
- Achieved promising results in defining an effective and deployable prognostic model.
- Generated an explainable artificial intelligence (AI) model for MCL prognosis.
- The developed model demonstrated superior performance compared to traditional prognostic indexes.
Conclusions:
- The novel AutoML-Med-derived prognostic model shows significant potential for improving mantle cell lymphoma patient care.
- An explainable AI approach offers a viable path for creating more accurate prognostic tools in oncology.
- This work supports future investigations into AI-driven precision medicine for hematologic malignancies.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...